References
- Farrell G C. Acute viral hepatitis. Med J Aust 1998; 168: 565–570
- Farrell G C. Chronic viral hepatitis. Med J Aust 1998; 168: 619–626
- Wood A J. Vaccines to prevent viral hepatitis. N Engl J Med 1997; 3: 196–204
- Banatvala J E, van Damme P. Hepatitis B vaccine—do we need boosters?. J Viral Hepatol 2003; 10: 1–6
- Aggarwal R, Ranjan P. Preventing and treating hepatitis B infection. BMJ 2004; 329: 1080–1086
- O'Sullivan B G, Gidding H F, Law M, et al. Estimates of chronic hepatitis B virus infection in Australis. Aust NZ J Public Health 2004; 3: 212–218
- Kane M A, Alter M J, Hadler S C, Margolis H S. Hepatitis B infection in the United States: recent trends and future strategies for control. Am J Med 1989; 87(suppl 3A)11–13s
- Thompson S C, Stevenson E, Wilby R, Crofts N. Hepatitis B infection in Victoria 1992: time to review the high-risk vaccination strategy. Med J Aust 1993; 159: 562–563
- Thompson S C, Ogilvie E L, Veit F C, Crofts N. Juvenile offenders and hepatitis B: risk, vaccine uptake and vaccination status. Med J Aust 1998; 169: 306–309
- Alter M J, Hadler S C, Margolis H S, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccine strategies. JAMA 1990; 263: 1218–1222
- Unlinked Anonymous Surveys Steering Group. Prevalence of HIV and hepatitis infection in the United Kingdom in 2000. Survey of injecting drug users in contact with drug services. Department of Health, London 2001
- Members of Australian Technical Advisory Group on Immunisation. The Australian immunisation handbook. Department of Health and Aging, Canberra 2003
- Winstock A R. High risk groups are still not being vaccinated. BMJ 2005; 330: 198
- Boughton C R, Hawkes R A. Viral hepatitis and the drug cult: a brief socio-epidemiological study in Sydney. Aust NZ J Med 1980; 10: 157–161
- Kuo I, Mudrick D W, Strathdee S A, Thomas D L, Sherman S G. Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug users. Clin Infect Dis 2004; 4: 587–590
- Best D, Noble A, Finch E, Gossop M, Sidwell C, Strang J. Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment. BMJ 1999; 319: 290–291
- Stanford M P, Black T R, March L M, Holt D A, Campbell D H. Hepatitis B vaccination rates among staff at a district general hospital. Med J Aust 1995; 162: 304–306
- McGregor J, Marks P J, Hayward A, Bell Y, Slack R C. Factors influencing hepatitis B vaccine uptake in injecting drug users. J Public Health Med 2003; 25: 165–170
- Datt N, Feinmann C. The practical business of treatment—13. Providing health care for drug users?. Br J Addict 1990; 85: 1571–1575
- Thompson S C, Oman K. Why should Australia adopt universal infant hepatitis B vaccination?. Aust N Z J Public Health 1996; 20: 436–439
- Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991; 40: 1–25
- Quaglio G, Lugoboni F, Mezzelani P. HBV vaccination should be performed in service centres for drug users: an Italian experience. J Public Health (Oxf) 2004; 26: 320